How Did Breast Cancer Patients Fare during Different Phases of the COVID-19 Pandemic in Norway Compared to Age-Matched Controls?

• Published in: Cancers Vol. 16; no. 3; p. 602
• Main Authors: Svendsen, Karianne, Leithe, Sigrid, Trewin-Nybråten, Cassia B., Balto, Aina, Nes, Lise Solberg, Meland, Anders, Børøsund, Elin, Kiserud, Cecilie E., Reinertsen, Kristin Valborg, Eriksen, Hege R., Gjelsvik, Ylva Maria, Ursin, Giske
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.01.2024
• Subjects: Breast cancer; Cancer patients; Care and treatment; Children; Comparative analysis; COVID-19; Exercise; Fatigue; Health aspects; Infection; Insomnia; Medical research; Medicine, Experimental; Pandemics; Quality of life; Sleep disorders; Norway; COVID-19; HRQoL; breast cancer; family; EORTC
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers16030602

Little is known about how health-related quality of life (HRQoL) in breast cancer cases differed from that of controls during and after the COVID-19 pandemic. This study used data from an ongoing, nationwide HRQoL survey of 4279 newly diagnosed breast cancer cases and 2911 controls to investigate how breast cancer patients fared during different phases of the pandemic compared to controls. Responders during 2020–2022 were categorized into three COVID-19-related phases: the social restrictions phase, the high infection rate phase, and the post-pandemic phase. Across phases, breast cancer cases had significantly worse scores in most HRQoL domains compared to controls. Apart from slightly more insomnia in the high infection rate phase for both cases and controls, and better social functioning for young cases in the post-COVID-19 phase, the case-control differences in HRQoL remained consistent across phases. When the phases were assessed as one period, young women and those living with children <18 years of age fared the worst among breast cancer cases, while single women fared the worst among controls. In contrast, controls living with children <18 years of age exhibited better HRQoL than controls without children. In summary, women with breast cancer did not appear to fare differently than controls in terms of HRQoL across COVID-19 phases. However, breast cancer cases with young children fared worse in their HRQoL than other breast cancer cases.